Q-Line Biotech SME IPO Details
SME
Upcoming
Everything you need to know about the Q-Line Biotech IPO. Track the latest updates, GMP trends, and subscription status.
Open
21 May
2026
Close
25 May
2026
Allotment
26 May
2026
Listing
29 May
2026
IPO Review
Coming Soon
IPO GMP
₹ 0
(--)
IPO Subscription Subscription
--
IPO Summary
IPO Dates
21 to 25 May, 2026
Price Band
₹326 to ₹343
Face Value
₹10
Lot Size
400 Shares
Issue Size
₹251 Cr
Listing On
NSE SME
Min Investment
₹ 2,74,400
What is the Q-Line Biotech IPO Timetable?
Track the IPO schedule and key events.
| Event | Date | Day |
|---|---|---|
| IPO Open Date | 21 May, 2026 Thu | Thursday |
| IPO Close Date | 25 May, 2026 Mon | Monday |
| Basis of Allotment | 26 May, 2026 Tue | Tuesday |
| Refunds Initiated | 27 May, 2026 Wed | Wednesday |
| Credit to Demat | 27 May, 2026 Wed | Wednesday |
| Listing Date | 29 May, 2026 Fri | Friday |
What is the Q-Line Biotech IPO Lot Size?
Bidding in multiples of 400 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 800 | ₹2,74,400 |
| Retail (Max) | 2 | 800 | ₹2,74,400 |
| HNI (Min) | 3 | 1200 | ₹4,11,600 |
About Q-Line Biotech
No company details available yet.
Objects of the Issue
| Issue Object | Estimate Amount |
|---|---|
Issue Object
Estimate Amount
Company Financials
Summary of financial performance including revenue, profit, and debt levels will be populated here.
IPO Reservation
| Investor Category | Reservation |
|---|
Promoters and Shareholding Details
Promoter holding details will be updated as soon as they are officially announced.
Frequently Asked Questions
What is the GMP of Q-Line Biotech?
The current Grey Market Premium (GMP) of Q-Line Biotech is ₹ 0.
What is the Q-Line Biotech IPO Price Band?
The price band for Q-Line Biotech IPO is 343.
When is the Q-Line Biotech IPO Allotment?
The allotment date for Q-Line Biotech IPO is May 26, 2026.
How to check Q-Line Biotech IPO Allotment Status?
You can check the allotment status on the IPO Allotment Status page or on the registrar's website .
Discussion 0
No comments yet
Be the first to share your thoughts!